Logo image of ALCAB.PA

CABASSE SA (ALCAB.PA) Stock Fundamental Analysis

EPA:ALCAB - Euronext Paris - Matif - FR001400DIY6 - Common Stock - Currency: EUR

0.461  -0.04 (-7.24%)

Fundamental Rating

1

Overall ALCAB gets a fundamental rating of 1 out of 10. We evaluated ALCAB against 31 industry peers in the Household Durables industry. ALCAB may be in some trouble as it scores bad on both profitability and health. ALCAB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALCAB had negative earnings in the past year.
In the past 5 years ALCAB always reported negative net income.
In multiple years ALCAB reported negative operating cash flow during the last 5 years.
ALCAB.PA Yearly Net Income VS EBIT VS OCF VS FCFALCAB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -500K -1M -1.5M

1.2 Ratios

ALCAB has a Return On Assets of -10.70%. This is amonst the worse of the industry: ALCAB underperforms 93.55% of its industry peers.
Industry RankSector Rank
ROA -10.7%
ROE N/A
ROIC N/A
ROA(3y)-8.05%
ROA(5y)-9.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCAB.PA Yearly ROA, ROE, ROICALCAB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 400

1.3 Margins

ALCAB has a better Gross Margin (62.84%) than 83.87% of its industry peers.
In the last couple of years the Gross Margin of ALCAB has grown nicely.
ALCAB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
ALCAB.PA Yearly Profit, Operating, Gross MarginsALCAB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, ALCAB has less shares outstanding
ALCAB has a worse debt/assets ratio than last year.
ALCAB.PA Yearly Shares OutstandingALCAB.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
ALCAB.PA Yearly Total Debt VS Total AssetsALCAB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

ALCAB has an Altman-Z score of 0.29. This is a bad value and indicates that ALCAB is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALCAB (0.29) is worse than 93.55% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.29
ROIC/WACCN/A
WACCN/A
ALCAB.PA Yearly LT Debt VS Equity VS FCFALCAB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 2M 4M

2.3 Liquidity

A Current Ratio of 1.00 indicates that ALCAB should not have too much problems paying its short term obligations.
The Current ratio of ALCAB (1.00) is worse than 80.65% of its industry peers.
A Quick Ratio of 0.39 indicates that ALCAB may have some problems paying its short term obligations.
ALCAB has a Quick ratio of 0.39. This is amonst the worse of the industry: ALCAB underperforms 93.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.39
ALCAB.PA Yearly Current Assets VS Current LiabilitesALCAB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 72.24% over the past year.
The Revenue has decreased by -5.39% in the past year.
ALCAB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.61% yearly.
EPS 1Y (TTM)72.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.58%
Revenue 1Y (TTM)-5.39%
Revenue growth 3Y4.61%
Revenue growth 5YN/A
Sales Q2Q%-10.03%

3.2 Future

ALCAB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -48.16% yearly.
The Revenue is expected to decrease by -27.58% on average over the next years. This is quite bad
EPS Next Y1249.84%
EPS Next 2Y-326.85%
EPS Next 3Y-48.16%
EPS Next 5YN/A
Revenue Next Year10.51%
Revenue Next 2Y-36.35%
Revenue Next 3Y-27.58%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALCAB.PA Yearly Revenue VS EstimatesALCAB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
ALCAB.PA Yearly EPS VS EstimatesALCAB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALCAB. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALCAB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCAB.PA Price Earnings VS Forward Price EarningsALCAB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCAB.PA Per share dataALCAB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

ALCAB's earnings are expected to decrease with -48.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-326.85%
EPS Next 3Y-48.16%

More info and screens

0

5. Dividend

5.1 Amount

ALCAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CABASSE SA

EPA:ALCAB (5/9/2025, 7:00:00 PM)

0.461

-0.04 (-7.24%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap958.88K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.49
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.27
BVpS-0.02
TBVpS-0.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.7%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.84%
FCFM N/A
ROA(3y)-8.05%
ROA(5y)-9.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1
Quick Ratio 0.39
Altman-Z 0.29
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.58%
EPS Next Y1249.84%
EPS Next 2Y-326.85%
EPS Next 3Y-48.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.39%
Revenue growth 3Y4.61%
Revenue growth 5YN/A
Sales Q2Q%-10.03%
Revenue Next Year10.51%
Revenue Next 2Y-36.35%
Revenue Next 3Y-27.58%
Revenue Next 5YN/A
EBIT growth 1Y61.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year402.5%
EBIT Next 3Y16.72%
EBIT Next 5YN/A
FCF growth 1Y104.27%
FCF growth 3Y-43.11%
FCF growth 5YN/A
OCF growth 1Y104.27%
OCF growth 3Y-43.11%
OCF growth 5YN/A